Insight

Insights,

ADVI’s Lindsay Bealor Greenleaf spoke to AIS Health about the drug pricing provisions currently being considered in spending bill negotiations and how they would impact the payment & reimbursement of drugs.

Insights,

ADVI Finds New CAR-T DRG 018 Used by 10 New Hospitals in FY 2021 and 11% Increase in Reimbursement

Insights,

ADVI’s Strategic Analytics and Value Economics (SAVES) team found that despite an increase in Part D enrollment in 2020, there was a 12% decrease in the number of Part D beneficiaries reaching catastrophic coverage.

Insights,

After additional guidance and threat of audit from CMS, ADVI re-examined hospital transparency data to find that most hospitals have not updated their pricing information.

Insights,

ADVI’s Head of Analytics, Caitlin Sheetz, spoke with Susan Morse about the FY 2022 IPPS proposed rule.

Insights,

ADVI’s VP and policy expert, Lindsay Bealor Greenleaf spoke with BioWorld about Pres. Biden announcing his support to lift patent protections for COVID-19 vaccines and potential consequences

Insights,

Our Head of Analytics, Caitlin Sheetz, talked with Robert King at FierceHealthcare about CMS’ commitment to price transparency after a proposal to pull MA requirements

Insights,

Our Head of Analytics, Caitlin Sheetz, spoke with Guy Boulton from the Milwaukee Journal Sentinel about the secrecy surrounding prices in healthcare and the rule requiring hospitals to disclose costs.

Insights,

Vice President of Policy Lindsay Bealor Greenleaf explains why the latest proposed rule for Medicaid would actually raise out-of-pocket costs for patients in commercial plans with the Morning Consult